Question Title

* 1. How many years have you been in practice?

Question Title

* 2. How many patients with HIV do you manage per week?  

Question Title

* 3. Please select the option that best describes your practice setting.

Question Title

* 4. After participating in this activity, how confident are you in the management of patients with HIV in your practice? 

Question Title

* 5. How committed are you to making changes in your practice based on your participation in this activity?  

Question Title

* 6. Which of the following best describes the impact of this activity on your performance?

Question Title

* 7. Which new strategies/skills/information will you apply to your area of practice? Please select all that apply.

Question Title

* 8. What barriers do you see to making changes in your practice? Please select all that apply.

Question Title

* 9. Please rate your level of agreement by checking the appropriate rating.
5 = Strongly agree, 4 = Agree, 3 = Neutral, 2 = Disagree, 1 = Strongly disagree

After participating in today’s activity, I am now better able to:

  Strongly agree Agree Neutral Disagree Strongly disagree
Select ART regimens that minimize drug-drug interactions and toxicities, support adherence, and consider patient and systemic factors including patient preference
Summarize new paradigms and approaches to treating and managing HIV, including potential two-drug ARV combinations

Question Title

* 10. Please rate your level of agreement by checking the appropriate rating.
5 = Strongly agree, 4 = Agree, 3 = Neutral, 2 = Disagree, 1 = Strongly disagree

  Strongly agree Agree Neutral Disagree Strongly disagree
Faculty for this activity was effective
Content was scientifically rigorous and evidence based
Avoided commercial bias or influence

Question Title

* 11. As a result of your participation in this activity, what is the one change you are most likely to implement in your practice?

Question Title

* 12. Please list any clinical issues/problems within your scope of practice you would like to see addressed in future educational activities for HIV.

Question Title

* 13. If you indicated that you perceived commercial bias or influence, please describe:

T